Rodica Busui, MD, PhD, discusses her role as ADA President of Medicine & Science. Dr. Busui is also the recipient of the 2023 Banting Medal for Leadership and Service, which recognizes her outstanding leadership and service to the American Diabetes Association^®.

Carmella Evans-Molina, MD, PhD, discusses the work that led her to be named the recipient of the ADA's 2023 Outstanding Scientific Achievement Award. She delivered an award lecture Monday morning, and a recording can be viewed on the virtual platform at ADA2023.org.

Scientific Sessions Meeting Planning Committee Chair Alice Y.Y. Cheng, MD, FRCPC, previews noteworthy sessions on Monday’s schedule, plus Ania M. Jastreboff, MD, PhD, and Jennifer B. Green, MD, offer sneak peeks at Monday afternoon symposia that will feature results from clinical trials.

Amy Valent, DO, MCR, and Teri Hernandez, PhD, RN, debate whether pregnant persons with gestational diabetes should follow a reduced-carbohydrate meal plan. The subject was the focus of a full debate session on Saturday at the Scientific Sessions, and registered attendees can now view that recording and others on the virtual meeting platform at ADA2023.org.

Lisa Staimez, PhD, MPH, and Sridharan Raghavan, MD, PhD, debate population health approaches versus personalized medicine approaches in type 2 diabetes prevention. The subject was the focus of a full debate session on Friday at the Scientific Sessions, and registered attendees can now view that recording on the virtual meeting platform at ADA2023.org.

ADA National Health Disparities Committee Chair Ashby F. Walker, PhD, discusses the impactful abstracts on health disparities and health equity that the committee selected as part of the 83rd Scientific Sessions. The Poster Hall is open Sunday from 7:30 a.m. to 6:30 p.m. PT and Monday from 7:30 a.m. to 2:00 p.m. PT.

Scientific Sessions Meeting Planning Committee Chair Alice Y.Y. Cheng, MD, FRCPC, previews noteworthy sessions on Sunday's schedule.

Matthias H. Tschöp, MD, discusses the research that led him to be named the recipient of the ADA's 2023 Banting Medal for Scientific Achievement. He will deliver an award lecture on Sunday at 10:30 a.m. PT in Halls GH. Watch a livestream or catch the recording on-demand on the virtual platform at ADA2023.org.

Alka M. Kanaya, MD, discusses the research that led her to be named the recipient of the ADA's 2023 Kelly West Award for Outstanding Achievement in Epidemiology. She will deliver an award lecture on Saturday at 3:15 p.m. PT in Ballroom 6A-B. Watch a livestream or catch the recording on the virtual platform at ADA2023.org.

SURMOUNT 2 principal investigator W. Timothy Garvey, MD, discusses data presented Friday at the Scientific Sessions on tirzepatide use for obesity and type 2 diabetes. Watch an on-demand recording of that symposium, SURMOUNT 2 Trial Results and Potential Role of Tirzepatide in Treating Obesity in Type 2 Diabetes, on the virtual platform at ADA2023.org.

Scientific Sessions Meeting Planning Committee Chair Alice Y.Y. Cheng, MD, FRCPC, previews noteworthy sessions on Saturday’s schedule.

Scientific Sessions Meeting Planning Committee Chair Alice Y.Y. Cheng, MD, FRCPC, outlines some of the changes in this year's program and previews noteworthy sessions on Friday.

ADA Chief Scientific and Medical Officer Robert Gabbay, MD, PhD, and ADA Vice President of Research and Science Marlon Pragnell, PhD, highlight what attendees can expect at the 83rd Scientific Sessions.

This year's 5K @ ADA run/walk brought together participants in New Orleans and around the globe in a virtual challenge from June 1 to June 5. To learn more about the challenge or to view results and photos, visit ADA5K.com.

Frances M. Ashcroft, DBE, FRS, FMedSci, recipient of the ADA’s 2022 Banting Medal for Scientific Achievement, shares more about how she came to be involved in the science of diabetes. Dr. Ashcroft presented the Banting Medal lecture, Metabolic Regulation of Insulin Secretion in Health and Disease, on Sunday at the Scientific Sessions. A recording can be viewed on-demand at ADA2022.org.

Ania M. Jastreboff, MD, PhD, shares details about the results of the SURMOUNT-1 phase 3 obesity trial of tirzepatide. Dr. Jastreboff helped present findings Saturday during the Scientific Sesssions, and a recording of that presentation can be found at ADA2022.org.

Anna Gloyn, DPhil, shares thoughts about the work that led her to be named the recipient of the ADA's 2022 Outstanding Scientific Achievement Award. View her Monday award lecture live on on-demand at ADA2022.org.

Ashby F. Walker, PhD, from the ADA's Health Disparities Committee, shares insights about some of the science and topics that attendees can see represented at the 82nd Scientific Sessions Poster Hall, open until 2 p.m. CT Monday, and virtual e-Poster page, which can be viewed anytime through ADA2022.org.

ADA special interest group leaders have presented awards to young investigators who are showcasing research at the 82nd Scientific Sessions. Visit the Poster Hall, open until 6:30 p.m. CT Sunday and from 7:30 a.m. to 2:00 p.m. CT Monday, to view these and the hundreds of other posters at this year's meeting.

Visit the American Diabetes Association's booth at the Scientific Sessions Exhibit Hall, which is open from 10:00 a.m. to 4:00 p.m. CT on Sunday and 10:00 a.m. to 2:00 p.m. CT on Monday.

Steven J. Russell, MD, PhD, shares more about the Insulin-Only Bionic Pancreas Pivotal Trial and the results of the study, which were presented Friday during a mini-symposium at the Scientific Sessions. An on-demand recording of that session is available at ADA2022.org

Meeting attendees In New Orleans share the topics, sessions, and experiences that they're most looking forward to during the five days of the ADA's 82nd Scientific Sessions.

The recipient of the 2022 Outstanding Educator in Diabetes Award, Amy Hess-Fischl, MS, RDN, LDN, BC-ADM, CDCES, shares thoughts about the importance of her work as a diabetes care and education specialist. View her Saturday award lecture live or on-demand at ADA2022.org.

ADA President of Health Care & Education Otis W. Kirksey, PharmD, RPh, CDCES, BC-ADM, shares the importance of treating patients with care and empathy. View his Saturday address to the Scientific Sessions live or on-demand at ADA2022.org.

A full program awaits on the second day of the meeting. Scientific Sessions Planning Committee Chair Dana Dabelea, MD, PhD, previews some of the day's highlights.

On the opening day of the meeting, Chair of the 82nd Scientific Sessions Meeting Planning Committee Dana Dabelea, MD, PhD, previews the day's highlights.

Nicole Johnson, ADA Vice President of Operations, Science and Health Care, highlights sessions and resources that attendees won't want to miss.

Walt Leger of New Orleans & Company welcomes the American Diabetes Association back to the Crescent City.

More than 11,500 participants from almost 120 countries took part in the five days of groundbreaking science presented at the 81st Scientific Sessions. Planning is underway for the 82nd Scientific Sessions, scheduled for June 2022 in New Orleans.

More than 5,100 participants from around the globe completed this year’s 5K@ADA Virtual Challenge, sponsored by Novo Nordisk.

ADA CEO Tracey D. Brown, MBA, BChE, discusses the work the ADA has continued to do during the COVID-19 pandemic and where the association will focus its efforts in the diabetes community going forward. She also delivered remarks to the 81st Scientific Sessions on Saturday morning, and that on-demand video can be viewed at ADA2021.org.

Learn about the benefits of ADA membership, including educational resources, an online forum for professionals at all stages of their careers, Professional Interest Groups, the Women's Interprofessional Network of ADA (WIN ADA), journals and books, a patient education library, and more. Become a member today.

Systemic health inequity contributes to worse outcomes and higher risk for diabetes and many other diseases. The ADA makes a call for ensuring health equity for all. Learn more at diabetes.org/HealthEquityNow.

Scientific Sessions Meeting Planning Committee Chair Dana Dabelea, MD, PhD, previews the highlights of the educational program on the final day of the virtual meeting.

Denise Charron-Prochownik, PhD, RN, CPNP, FAAN, speaks about her efforts to educate teenage girls with diabetes about their reproductive health. She also addressed the 81st Scientific Sessions upon receiving the Outstanding Educator in Diabetes Award on Saturday. View her lecture.

Kristen J. Nadeau, MD, MS, speaks about her work treating diabetes in youth. She is the recipient of the 2021 Outstanding Scientific Achievement Award. View her lecture.

A full educational program awaits on the fourth day of the virtual meeting. Scientific Sessions Meeting Planning Committee Chair Dana Dabelea, MD, PhD, previews the day’s highlights.

Nicholas J. Wareham, FMedSci, FRCP, FFPHM, MBBS, MSc, PhD, reflects on his career in the diabetes community. He is the recipient of the 2021 Kelly West Award for Outstanding Achievement in Epidemiology. View his lecture on-demand at ADA2021.org.

Jens Juul Holst, MD, DrMedSci, speaks about his contributions to the diabetes community as a trailblazing incretin researcher. View the Banting Medal Lecture.

ADA President, Medicine & Science, Ruth S. Weinstock, MD, PhD, speaks about some of the ADA's ongoing efforts and future plans. She will address the 81st Scientific Sessions beginning at 10:15 a.m. ET Sunday, June 27. View the session at ADA2021.org.

As the third day of the 81st Scientific Sessions gets underway, Scientific Sessions Meeting Planning Committee Chair Dana Dabelea, MD, PhD, previews the day's highlights.

The educational program of the 81st Scientific Sessions includes several sessions that focus on COVID-19 and its impact on people living with diabetes. Robert H. Eckel, MD, ADA Past President, Science and Medicine, highlights these and the ADA's commitment to funding research related to COVID-19 and diabetes.

ADA President, Health Care & Education, Cynthia E. Muñoz, PhD, MPH, discusses health equity and ADA mental health resources for people living with diabetes. She will address the 81st Scientific Sessions in a session beginning at 10:15 a.m. ET Saturday, June 26, that includes remarks from ADA CEO Tracey D. Brown, MBA, BChE, and Outstanding Educator in Diabetes Award recipient Denise Charron-Prochownik, PhD, CPNP, RN, FAAN. View the session at ADA2021.org.

A full educational program awaits at the second day of the virtual meeting. Scientific Sessions Meeting Planning Committee Chair Dana Dabelea, MD, PhD, previews the day's highlights.

The ADA will commemorate the centennial anniversary of the discovery of insulin at this year’s 81st Scientific Sessions with a special symposium on Saturday, June 26. Modern giants in the field will discuss the synthesis, secretion, and action of endogenous insulin, as well as its pharmacological modifications and the future of insulin as therapy. Read a preview of the session.

Robert Gabbay, MD, PhD, ADA Chief Scientific and Medical Officer, outlines how the COVID-19 pandemic has served as an accelerant of change for the ADA and the health care community.

On the opening day of the virtual meeting, Scientific Sessions Meeting Planning Committee Chair Dana Dabelea, MD, PhD, previews the day's meeting highlights.

ADA CEO Tracey D. Brown shares her excitement for five days of science, innovation, and networking within the diabetes community taking place June 25–29 at the 81st Scientific Sessions.

The 81st Scientific Sessions will incorporate expanded opportunities for attendees to interact with speakers, exhibitors, and one another.

The ADA is accepting Advance Registration for the 81st Scientific Sessions. The implications of COVID-19 on diabetes, major trial results, and the 100th anniversary of the discovery of insulin are a few highlights of the educational program at this virtual meeting taking place 25–29.

The ADA is accepting registrations for the 81st Scientific Sessions. This virtual meeting taking place June 25–29 will feature hundreds of oral presentations and poster presentations highlighting cutting-edge innovations in diabetes research, prevention, and care.